Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

441
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
441
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

16.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.6K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

5.6K
5.6K
Chromatin Position Affects Gene Expression02:35

Chromatin Position Affects Gene Expression

24.9K
Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
24.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

6.9K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.9K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

480
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
480

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling" [Cellular Signaling, 2015 Sep 26; 27(12): 2515-2523].

Cellular signalling·2026
Same author

MT2A facilitates the malignant progression of clear cell renal cell carcinoma by activating the TFAP2A/YAP axis via histone lactylation.

Chemico-biological interactions·2026
Same author

Sophocarpine Alleviates Renal Ischemia-Reperfusion Injury by Mitigating Oxidative Stress and Mitochondrial Dysfunction via the SIRT1/PGC-1α Axis.

Biomedicines·2026
Same author

A pathological morphology parameter-based prognostic nomogram for high-risk prostate cancer patients treated with neoadjuvant therapy followed by radical prostatectomy: a retrospective study.

World journal of surgical oncology·2026
Same author

Goose astrovirus genotype 2 induces autophagy in goose renal tubular epithelial cells requiring the ERK2 signaling pathway: Pharmacological evidence for a pro-viral role of autophagy.

Poultry science·2026
Same author

The Correlation Between the Prognostic Nutritional Index and Sudden Sensorineural Hearing Loss With Comorbid Nonalcoholic Fatty Liver Disease: A Prospective Study.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2026

Related Experiment Video

Updated: Feb 6, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

17.2K

The expression and function of RASAL2 in renal cell carcinoma angiogenesis.

Ke Hui1, Yangyang Yue1, Shiqi Wu1

  • 1Department of Urology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, P.R. China.

Cell Death & Disease
|August 31, 2018
PubMed
Summary

RASAL2 acts as a tumor suppressor in renal cell carcinoma (RCC) by inhibiting angiogenesis. Its silencing correlates with poor survival, and restoring its function may overcome resistance to anti-vascular drugs.

More Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

14.2K
Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

9.5K

Related Experiment Videos

Last Updated: Feb 6, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

17.2K
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

14.2K
Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

9.5K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Renal cell carcinoma (RCC) frequently develops resistance to anti-vascular therapies.
  • The molecular mechanisms driving this resistance and tumor progression are not fully understood.
  • Identifying novel therapeutic targets is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the role of RASAL2 (RAS GTPase-activating protein) in renal cell carcinoma.
  • To elucidate the molecular mechanisms by which RASAL2 affects tumor angiogenesis and drug resistance.
  • To explore the potential of targeting the RASAL2 pathway for RCC treatment.

Main Methods:

  • Analysis of RASAL2 epigenetic silencing in RCC patient samples.
  • In vitro and in vivo studies to assess the effect of RASAL2 on angiogenesis.
  • Investigation of the molecular pathway involving RASAL2, GSK3β, c-FOS, and VEGFA.
  • Utilizing specific inhibitors and small interfering RNA (siRNA) to modulate pathway components.

Main Results:

  • RASAL2 is frequently epigenetically silenced in RCC, and its loss correlates with reduced patient survival.
  • RASAL2 demonstrates significant inhibition of RCC angiogenesis both in vitro and in vivo.
  • RASAL2 activates GSK3β (glycogen synthase kinase 3 beta) by reducing Ser9 phosphorylation.
  • This activation leads to decreased expression of c-FOS and vascular endothelial growth factor A (VEGFA).

Conclusions:

  • RASAL2 functions as a tumor suppressor in renal cell carcinoma by targeting angiogenesis.
  • The RASAL2/p-GSK3β/c-FOS/VEGFA pathway is a key regulator of RCC angiogenesis.
  • Targeting this pathway offers a potential strategy to overcome resistance to anti-vascular therapies in RCC.